cyc 202 has been researched along with nu6102 in 4 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (nu6102) | Trials (nu6102) | Recent Studies (post-2010) (nu6102) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 32 | 0 | 22 |
| Protein | Taxonomy | cyc 202 (IC50) | nu6102 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | 0.5 | |
| Cyclin-T1 | Homo sapiens (human) | 2.585 | |
| Rho-associated protein kinase 2 | Homo sapiens (human) | 0.6 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.0095 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.097 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.006 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.4087 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.1329 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.0074 | |
| Cyclin-A2 | Homo sapiens (human) | 0.1303 | |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.2598 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.0335 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.1041 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0081 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.04 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 3.7667 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 2.09 | |
| Cyclin-H | Homo sapiens (human) | 3.45 | |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 2.5 | |
| Cyclin-A1 | Homo sapiens (human) | 0.0054 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.2985 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.9 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.117 | |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | 0.8 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.0095 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.0074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
| Cheng, W; Kan, Q; Li, Y; Tian, X; Wang, S; Wei, H; Yang, Z | 1 |
| Edwards, DP; Moore, NL; Weigel, NL | 1 |
2 review(s) available for cyc 202 and nu6102
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
Topics: Animals; Crystallography, X-Ray; Cyclin-Dependent Kinases; Humans; Molecular Structure; Protein Binding; Protein Kinase Inhibitors | 2019 |
2 other study(ies) available for cyc 202 and nu6102
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cyclin A2; Cyclin-Dependent Kinase 2; Female; Humans; Purines; Receptors, Progesterone; RNA, Messenger; Roscovitine | 2014 |